Cancer Blog
- Dr. Robert Nagourney -

Stage 4 Cancer Patients Need Answers Not Questions: Genomic Variants Of Uncertain Significance (VUS) Don’t Help!

Dr. Robert A. Nagourney, MD

Sep 5
3 min

Stage 4 Cancer Patients Need Answers Not Questions: Genomic Variants Of Uncertain Significance (VUS) Don’t Help!

Genomic findings are a first step. They find targets. The question the patient wants to answer is “Can I hit the target?”

Metastatic or Recurrent Cancer Patients Can’t Afford to Guess

Dr. Robert A. Nagourney, MD

Jul 18
3 min

Metastatic or Recurrent Cancer Patients Can’t Afford to Guess

Cancer patients deserve better. Every patient is unique. Their treatment should be as well.

A Ray of Hope in the Fight Against Stage 4 Colon Cancer

Dr. Robert A. Nagourney, MD

Apr 2
3 min

A Ray of Hope in the Fight Against Stage 4 Colon Cancer

Daniel Werner, a dedicated nurse and a loving fiancé and father, faced the grim reality of a stage 4 colon cancer diagnosis in December 2021

Much Heralded New Treatment For Pancreatic Cancer Approved by FDA: But Has it Moved The Dial?

Dr. Robert A. Nagourney, MD

Feb 21
2 min

Much Heralded New Treatment For Pancreatic Cancer Approved by FDA: But Has it Moved The Dial?

The NAPOLI-3 trail trial median survival of 11.1 months is exactly the same as the original FOLFIRINOX regimen from 13 years ago.

Functional Profiling for Cancer is Scientifically Validated by Peer-Review

Dr. Robert A. Nagourney, MD

Feb 9
2 min

Functional Profiling for Cancer is Scientifically Validated by Peer-Review

One of the critical advantages of Functional Profiling over traditional genomic testing is its focus on the actual response of cancer cells.

What Have Medical Oncologists Lost? Empathy!

Dr. Robert A. Nagourney, MD

Jan 31
3 min

What Have Medical Oncologists Lost? Empathy!

Cancer patients approach their diagnosis with a sense of terror. One day they are fine and feeling well and the next, a terminal diagnosis.

For Advanced Cancer Patients: Whose Life is It Anyway?

Dr. Robert A. Nagourney, MD

Jan 23
3 min

For Advanced Cancer Patients: Whose Life is It Anyway?

Rising corporate influence and focus on reimbursement in medicine now discourage doctors from straying from strict treatment guidelines.

Personalized Medicine Is More Than a Marketing Buzzword at Nagourney Cancer Institute

Dr. Robert A. Nagourney, MD

Jan 15
2 min

Personalized Medicine Is More Than a Marketing Buzzword at Nagourney Cancer Institute

Cancer therapy can be really expensive. But here's the kicker, Functional Profiling costs way less than receiving the incorrect treatment.

Hitting Cancer True and Straight: the Role of Tissue Analysis

Dr. Robert A. Nagourney, MD

Oct 30, 2023
3 min

Hitting Cancer True and Straight: the Role of Tissue Analysis

Although she showed some response, her disease persisted and she was being considered for surgery to remove the residual tumor...

Recurrent Lung Cancer Patients Need To “Get Down On It”

Dr. Robert A. Nagourney, MD

Oct 25, 2023
3 min

Recurrent Lung Cancer Patients Need To “Get Down On It”

George Brown is alive today because our laboratory analysis identified a simple 2 drug combination that now one else thought to give him.

A Triple Negative Breast Cancer Patient's Journey: Going the Extra Mile

Dr. Robert A. Nagourney, MD

Oct 10, 2023
3 min

A Triple Negative Breast Cancer Patient's Journey: Going the Extra Mile

This patient had recurrent breast cancer that upon biopsy proved to be triple negative.

Dr. Robert A. Nagourney, MD

Sep 26, 2023
2 min

Your Cancer Cure May Already Exist

Personalized treatment means more cured patients. More people survive cancer when our Functional Profiling system is used before treatment.

Pancreatic Cancer Surgery: Know What You Have Consented To!

Dr. Robert A. Nagourney, MD

Aug 30, 2023
2 min

Pancreatic Cancer Surgery: Know What You Have Consented To!

However, a new dilemma has arisen; the failure of surgeons to comply with Pancreatic Cancer patient’s wishes to have tissue submitted.

Stage 4 Cancer Patient Survivals: The Data Is In and It’s Not Good

Dr. Robert A. Nagourney, MD

Jul 24, 2023
2 min

Stage 4 Cancer Patient Survivals: The Data Is In and It’s Not Good

There has been talk of improved survival in cancer, most progress has reflected screening, early diagnosis, improved staging, and support.

Challenging Paradigms: The Management of Rectal Cancer

Dr. Robert A. Nagourney, MD

Jun 26, 2023
3 min

Challenging Paradigms: The Management of Rectal Cancer

One noteworthy case was a 78-year-old patient successfully treated without surgery.

Breakthrough for Young Patients with a Rare Form of Liver Cancer

Dr. Robert A. Nagourney, MD

Jun 2, 2023
2 min

Breakthrough for Young Patients with a Rare Form of Liver Cancer

Extremely rare liver cancer that mostly affects people in their twenties associated with a gene rearrangement, mostly lethal, until now.

For Medical Oncology, Déjà Vu All Over Again

Dr. Robert A. Nagourney, MD

May 19, 2023
3 min

For Medical Oncology, Déjà Vu All Over Again

Patients are being encouraged to contact the researchers to get biopsies and help take charge of their disease.

Nagourney Cancer Institute: 20-year Experience in 10,000 Patients

Dr. Robert A. Nagourney, MD

May 15, 2023
4 min

Nagourney Cancer Institute: 20-year Experience in 10,000 Patients

At the 2023 American Association for Cancer Research meeting in Orlando, we reported results of ex vivo analysis of programmed cell death.

Dr. Robert A. Nagourney, MD

Dec 30, 2022
2 min

A Year-End Reflection

2022 Reflection. Among our most important accomplishments in 2022 was the installation of a world-class Mass Spectrometry research program.

Cancer Blog - Dr. Robert Nagourney -

Cancer Blog
- Dr. Robert Nagourney -